Controls Clinical Trial
Official title:
A Mobile App to Improve Participation in Following-up Cohorts of Individuals Born Preterm: a Pragmatic Multicenter Randomized Controlled Trial
The main objective is to test the superiority of a newly developed mobile application - RECAP_MyLife - for data collection in cohort studies in order to increase participation in follow-up evaluations. We hypothesize that data collection through a mobile app will contribute to improvements in participation. An accurate assessment of the potential benefits and drawbacks of using this mobile technology tool for data collection in cohort studies will be conducted. For such, the study will be conducted in three cohorts developed in different temporal, cultural, and geographic contexts, increasing the generalization of the results found. This evaluation is intended to contribute to the development of more appropriate tools for data collection and consequently to increase participation in epidemiological studies.
Status | Not yet recruiting |
Enrollment | 310 |
Est. completion date | April 2021 |
Est. primary completion date | April 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 16 Years and older |
Eligibility | Inclusion Criteria: - Individuals aged 16 years or over - Individuals with no evidence of visual impairment, physical condition that may affect the ability to walk, or major cognitive or motor disabilities until the enrollment of the study - Individuals owning a smartphone with an Android software version 7 or newer. Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Instituto de Saude Publica da Universidade do Porto | Finnish Institute for Health and Welfare, Netherlands Organisation for Scientific Research, University of Tartu |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Participation | Defined as the total number of individuals who give consent to participate divided by the number of eligible individuals invited for the study. | Baseline | |
Secondary | Completion rates | Defined as the total number of participants who complete the follow-up evaluation divided by the number of participants who initiated the trial. | 4- weeks | |
Secondary | Usability | System Usability Scale (SUS) | 4-weeks | |
Secondary | Acceptability | Post-intervention questionnaire | 4- weeks | |
Secondary | Hawthorne effect - Physical activity | It will be measure if the data collection method affects physical activity, by comparing physical activity behavior (IPAQ-S) at baseline with results collected over the study period. | 1-week | |
Secondary | Hawthorne effect - Mood status | It will be measure if the data collection method affects mood status, by comparing mood status at baseline with results collected over the study period ("Circumplex Mood Model" scale). | 1-week | |
Secondary | Agreement of information (mobile app vs. questionnaire on mood status) | It will be assessed in the intervention arm, by comparing the results obtained from the mobile app with those obtained from the self-reported data collected by the "Circumplex Mood Model" scale. | 4-weeks | |
Secondary | Agreement of information (mobile app vs. questionnaire on physical activity) | It will be assessed in the intervention arm, by comparing the results obtained from the mobile app with those obtained from the self-reported data collected by IPAQ-S questionnaire. | 4-weeks | |
Secondary | Preference of methods | Participants of both arms will answer the following question: "If you could choose to participate through an app that measures your movements and asks you to fill in your emotions daily, or through short weekly online/mailed questionnaires, what would you choose? Why?" | 4-weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05118711 -
Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms
|
||
Completed |
NCT04201470 -
Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis
|
N/A | |
Completed |
NCT03680885 -
Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness
|
Early Phase 1 | |
Active, not recruiting |
NCT02471625 -
Traumatic Brain Injury Feasibility Study (EPIC-011)
|
N/A |